Mary R, Veinberg F, Couderc R
Service accueil-urgences, Hôpital Delafontaine, Saint-Denis.
Ann Biol Clin (Paris). 2003 Mar-Apr;61(2):127-37.
The prognosis of bacterial meningitis is critically dependent on a rapid causal diagnosis and implementation of an accurate treatment. However, clinical and biological parameters available within the few hours that follow the patient's admission are not reliable enough, except when bacteria are to be found in cerebrospinal fluid under the microscope. Therefore, the initial treatment of acute meningitis is still most of time presumptive so that the definitive diagnosis, however difficult, is often established when the therapeutic management has already been initiated. The use of biological markers, especially lymphokines and acute-phase proteins, has been proposed to facilitate the accuracy of the initial diagnosis. Today, C-reactive protein (CRP) is the most widely used inflammatory marker in emergency departments with aim to discriminate bacterial from viral infections. In 1998, Gerdes et al. published a meta-analysis from 35 studies questioning the usefulness of CRP in discriminating bacterial meningitis from viral meningitis. They outlined that the majority of authors proposed to use this inflammation marker as an additional tool for discriminating bacterial meningitis from viral meningitis, without having evaluated its independent contribution relative to other parameters such as white blood cell count, cerebrospinal fluid (CSF) white cell count, protein or glucose. Procalcitonin (PCT) is an acute-phase protein with faster kinetics than CRP, its concentration in serum rising within the few hours that follow the inception of a bacterial infection. Two French studies published in 1997 and 1998 have shown that, using a cut-off range of 0.5 through 2 ng/mL, the sensitivity and specificity of PCT were 100% in discriminating bacterial meningitis from viral meningitis. Some of the seven studies published since seemed to demonstrate the usefulness of PCT in diagnosing meningitis. Finally, PCT was used effectively to shorten unnecessary antibiotic treatment for children seen in an hospital in Paris (France) during summer 2000.
细菌性脑膜炎的预后严重依赖于快速的病因诊断和准确治疗的实施。然而,患者入院后数小时内可用的临床和生物学参数不够可靠,除非在显微镜下脑脊液中发现细菌。因此,急性脑膜炎的初始治疗大多数时候仍是推测性的,以至于在已经开始治疗管理时,往往才确立明确诊断,无论这一过程多么困难。有人提出使用生物标志物,尤其是淋巴因子和急性期蛋白,以提高初始诊断的准确性。如今,C反应蛋白(CRP)是急诊科最广泛使用的炎症标志物,旨在区分细菌感染和病毒感染。1998年,格德斯等人发表了一项对35项研究的荟萃分析,质疑CRP在区分细菌性脑膜炎和病毒性脑膜炎方面的效用。他们指出,大多数作者提议将这种炎症标志物作为区分细菌性脑膜炎和病毒性脑膜炎的辅助工具,却未评估其相对于其他参数(如白细胞计数、脑脊液白细胞计数、蛋白质或葡萄糖)的独立贡献。降钙素原(PCT)是一种急性期蛋白,其动力学比CRP更快,在细菌感染开始后的数小时内血清浓度就会升高。1997年和1998年发表的两项法国研究表明,使用0.5至2 ng/mL的临界值范围,PCT在区分细菌性脑膜炎和病毒性脑膜炎方面的敏感性和特异性均为100%。自那以后发表的七项研究中的一些似乎证明了PCT在诊断脑膜炎方面的效用。最后,2000年夏季在法国巴黎一家医院,PCT被有效地用于缩短对儿童不必要的抗生素治疗时间。